UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 35

Sortiert nach

Patient preferences for palliative treatment of locally advanced or metastatic gastric cancer and adenocarcinoma of the gastroesophageal junction: a choice-based conjoint analysis study from Germany

BMC cancer, 2016-12, Vol.16 (1), p.937-937, Article 937

2016

Volltextzugriff (PDF)

Need for numbers: assessing cancer survivors' needs for personalized and generic statistical information

BMC medical informatics and decision making, 2022-10, Vol.22 (1), p.260-14, Article 260

2022

Volltextzugriff (PDF)

Replicability of simulation studies for the investigation of statistical methods: the RepliSims project

Royal Society open science, 2024-01, Vol.11 (1), p.231003-18

2024

Volltextzugriff (PDF)

Three-Step Latent Class Analysis with Inverse Propensity Weighting in the Presence of Differential Item Functioning

Structural equation modeling, 2023-09, Vol.30 (5), p.737-748

2023

Volltextzugriff (PDF)

Causal Latent Class Analysis with Distal Outcomes: A Modified Three-Step Method Using Inverse Propensity Weighting

Multivariate behavioral research, 2024-07, p.1-31

2024

Volltextzugriff (PDF)

The association of circadian parameters and the clustering of fatigue, depression, and sleep problems in breast cancer survivors: a latent class analysis

Journal of cancer survivorship, 2023-10, Vol.17 (5), p.1405-1415

2023

Volltextzugriff (PDF)

A new three-step method for using inverse propensity weighting with latent class analysis

Advances in data analysis and classification, 2022-06, Vol.16 (2), p.351-371

2022

Volltextzugriff (PDF)

Heterogeneity in Quality of Life of Long‐Term Colon Cancer Survivors: A Latent Class Analysis of the Population‐Based PROFILES Registry

The oncologist (Dayton, Ohio), 2021-03, Vol.26 (3), p.e492-e499

2021

Volltextzugriff (PDF)

Burden of Illness Imposed by Severe Sepsis in Germany

The European journal of health economics, 2002, Vol.3 (2), p.77-82

2002

Volltextzugriff (PDF)

PCN115 - Patient Preferences For Palliative Treatment of Locally Advanced or Metastatic Gastric Cancer and Adenocarcinoma of the Gastrooesophageal Junction: a Choice-Based Conjoint Analysis Study From Germany

Value in health, 2015-05, Vol.18 (3), p.A209-A209

2015

Volltextzugriff (PDF)

Length of Hospital Stay and Associated Costs for Olanzapine vs. Haloperidol in the Treatment of Schizophrenia Relapse in Germany

The European journal of health economics, 2003, Vol.4 (2), p.85-89

2003

Volltextzugriff (PDF)

PDB80 A CONTROLLED, PROSPECTIVE LONGITUDINAL, INTERVENTIONAL, NATURALISTIC STUDY TO EVALUATE THE UNIQUE HEALTH CARE PROGRAM “CONVERSATION MAP©” FOR TURKISH PATIENTS WITH TYPE-2 DIABETES IN ONE GERMAN MAJOR CITY

Value in health, 2010, Vol.13 (7), p.A299-A299

2010

Volltextzugriff (PDF)

Costs of early retirement--the case of schizophrenia

Psychiatrische Praxis, 2004-11, Vol.31 Suppl 2, p.S238

Clouth, Johannes

2004

Volltextzugriff (PDF)

PMH20 IMPACT OF DISEASE SEVERITY ON DURATION OF HOSPITALIZATION IN PATIENTS WITH SCHIZOPHRENIA TREATED WITH OLANZAPINE OR HALOPERIDOL IN GERMANY: POST-HOC ANALYSIS OF DATA COLLECTED IN THE GEO STUDY

Value in health, 2009, Vol.12 (7), p.A354-A354

2009

Volltextzugriff (PDF)

PMH33 STRUCTURAL EQUATION MODELLING OF SCHIZOPHRENIA EARLY RETIREMENT IN GERMANY

Value in health, 2006-11, Vol.9 (6), p.A319-A320

2006

Volltextzugriff (PDF)

PCV133 PRACTICE PATTERNS AND QUALITY OF LIFE IN ACUTE CORONARY SYNDROME PATIENTS IN 2008–2009: BASELINE RESULTS FOR GERMANY FROM THE ANTIPLATELET TREATMENT OBSERVATIONAL REGISTRY II (APTOR II)

Value in health, 2010, Vol.13 (7), p.A366-A366

2010

Volltextzugriff (PDF)

PCN65 INPATIENT COST AND REIMBURSEMENT FOR PATIENTS WITH PROGRESSIVE MALIGNANT THORACIC NEOPLASM IN GERMANY

Value in health, 2009, Vol.12 (7), p.A268-A268

2009

Volltextzugriff (PDF)

PCV101 IS PRASUGREL COST-EFFECTIVE RELATIVE TO CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION FROM THE PERSPECTIVE OF THE GERMAN HEALTH CARE SYSTEM? A MODEL-BASED ANALYSIS

Value in health, 2009, Vol.12 (7), p.A331-A331

2009

Volltextzugriff (PDF)

Cost-effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in Germany

Journal of critical care, 2003-12, Vol.18 (4), p.217-227

2003

Volltextzugriff (PDF)

PMH24 GEO OBSERVATIONAL STUDY: 24 MONTHS CHARACTERISTICS OF SOCIOECONOMIC AND CLINICAL STATUS IN SCHIZOPHRENIA PATIENTS TREATED WITH OLANZAPINE AND HALOPERIDOL IN GERMANY

Value in health, 2005-11, Vol.8 (6), p.A203-A203

2005

Volltextzugriff (PDF)

PDB6: THE FINANCIAL EFFECTS OF INTERFACE AGREEMENTS FOR DIABETES MELLITUS: SOCIOECONOMIC RELEVANCE OF INTENSIVE CONTROLLED INSULIN THERAPY WITH INSULIN LISPRO COMPARED TO REGULAR HUMAN INSULIN

Value in health, 2000-09, Vol.3 (5), p.339-340

2000

Volltextzugriff (PDF)

Pharmacoeconomic evaluation of the treatment of schizophrenia in Germany: A comparison of olanzapine and haloperidol

European neuropsychopharmacology, 1999-09, Vol.9, p.294-294

1999

Volltextzugriff (PDF)

PMH2 GEO OBSERVATIONAL STUDY: 12 MONTH'S DISEASE CHARACTERISTICS, SIDE EFFECTS AND SOCIOECONOMIC STATUS IN SCHIZOPHRENIA PATIENTS TREATED WITH OLANZAPINE AND HALOPERIDOL IN GERMANY

Value in health, 2004-11, Vol.7 (6), p.776-776

2004

Volltextzugriff (PDF)

Hospitalisation and costs for schizophrenia relapse treatment in Germany

European psychiatry, 2002-05, Vol.17, p.151-151

2002

Volltextzugriff (PDF)

Deutsche Empfehlungen zur gesundheitsökonomischen Evaluation: Revidierte Fassung des Hannoveraner Konsens

Medizinische Klinik (München. 1983), 2000-01, Vol.95 (1), p.52-55

2000

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(35)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Patient preferences for palliative treatment of locally advanced or metastatic gastric cancer and adenocarcinoma of the gastroesophageal junction: a choice-based conjoint analysis study from Germany

Need for numbers: assessing cancer survivors' needs for personalized and generic statistical information

Replicability of simulation studies for the investigation of statistical methods: the RepliSims project

Three-Step Latent Class Analysis with Inverse Propensity Weighting in the Presence of Differential Item Functioning

Causal Latent Class Analysis with Distal Outcomes: A Modified Three-Step Method Using Inverse Propensity Weighting

The association of circadian parameters and the clustering of fatigue, depression, and sleep problems in breast cancer survivors: a latent class analysis

A new three-step method for using inverse propensity weighting with latent class analysis

Heterogeneity in Quality of Life of Long‐Term Colon Cancer Survivors: A Latent Class Analysis of the Population‐Based PROFILES Registry

Burden of Illness Imposed by Severe Sepsis in Germany

PCN115 - Patient Preferences For Palliative Treatment of Locally Advanced or Metastatic Gastric Cancer and Adenocarcinoma of the Gastrooesophageal Junction: a Choice-Based Conjoint Analysis Study From Germany

Length of Hospital Stay and Associated Costs for Olanzapine vs. Haloperidol in the Treatment of Schizophrenia Relapse in Germany

PDB80 A CONTROLLED, PROSPECTIVE LONGITUDINAL, INTERVENTIONAL, NATURALISTIC STUDY TO EVALUATE THE UNIQUE HEALTH CARE PROGRAM “CONVERSATION MAP©” FOR TURKISH PATIENTS WITH TYPE-2 DIABETES IN ONE GERMAN MAJOR CITY

Costs of early retirement--the case of schizophrenia

PMH20 IMPACT OF DISEASE SEVERITY ON DURATION OF HOSPITALIZATION IN PATIENTS WITH SCHIZOPHRENIA TREATED WITH OLANZAPINE OR HALOPERIDOL IN GERMANY: POST-HOC ANALYSIS OF DATA COLLECTED IN THE GEO STUDY

PMH33 STRUCTURAL EQUATION MODELLING OF SCHIZOPHRENIA EARLY RETIREMENT IN GERMANY

PCV133 PRACTICE PATTERNS AND QUALITY OF LIFE IN ACUTE CORONARY SYNDROME PATIENTS IN 2008–2009: BASELINE RESULTS FOR GERMANY FROM THE ANTIPLATELET TREATMENT OBSERVATIONAL REGISTRY II (APTOR II)

PCN65 INPATIENT COST AND REIMBURSEMENT FOR PATIENTS WITH PROGRESSIVE MALIGNANT THORACIC NEOPLASM IN GERMANY

PCV101 IS PRASUGREL COST-EFFECTIVE RELATIVE TO CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION FROM THE PERSPECTIVE OF THE GERMAN HEALTH CARE SYSTEM? A MODEL-BASED ANALYSIS

Cost-effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in Germany

PMH24 GEO OBSERVATIONAL STUDY: 24 MONTHS CHARACTERISTICS OF SOCIOECONOMIC AND CLINICAL STATUS IN SCHIZOPHRENIA PATIENTS TREATED WITH OLANZAPINE AND HALOPERIDOL IN GERMANY

PDB6: THE FINANCIAL EFFECTS OF INTERFACE AGREEMENTS FOR DIABETES MELLITUS: SOCIOECONOMIC RELEVANCE OF INTENSIVE CONTROLLED INSULIN THERAPY WITH INSULIN LISPRO COMPARED TO REGULAR HUMAN INSULIN

Pharmacoeconomic evaluation of the treatment of schizophrenia in Germany: A comparison of olanzapine and haloperidol

PMH2 GEO OBSERVATIONAL STUDY: 12 MONTH'S DISEASE CHARACTERISTICS, SIDE EFFECTS AND SOCIOECONOMIC STATUS IN SCHIZOPHRENIA PATIENTS TREATED WITH OLANZAPINE AND HALOPERIDOL IN GERMANY

Hospitalisation and costs for schizophrenia relapse treatment in Germany

Deutsche Empfehlungen zur gesundheitsökonomischen Evaluation: Revidierte Fassung des Hannoveraner Konsens

Suchergebnisse filtern